| |
X Axis |
Y Axis |
![]() |
| Variable: |
Health > Drug access |
Economy > Growth competitiveness score |
| Plot Display: |
Logarithmic (base 10) |
Logarithmic (base 10) |
| Definition: |
Population with access to essential drugs 2000. The data on access to essential drugs are based on statistical estimates received from World Health Organization (WHO) country and regional offices and regional advisers and through the World Drug Situation Survey carried out in 1998-99. These estimates represent the best information available to the WHO Department of Essential Drugs and Medicines Policy to date and are currently being validated by WHO member states. The department assigns the estimates to four groupings: very low access (0-49%), low access (50-79%), medium access (80-94%) and good access (95-100%). These groupings, used here in presenting the data, are often employed by the WHO in interpreting the data, as the actual estimates may suggest a higher level of accuracy than the data afford. b. |
The GCI, or the Growth competitiveness index, is composed of three pillars, all of which are widely accepted as being critical to economic growth: the quality of the macroeconomic environment, the state of a country's public institutions, and, given the increasing importance of technology in the development process, a country's technological readiness. The GCI aims specifically to gauge the ability of the world's economies to achieve sustained economic growth over the medium to long term. |
| Source: |
WHO (World Health Organization). 2001. Correspondence on access to essential drugs. Department of Essential Drugs and Medecines Policy. February. Geneva |
World economic forum - Global Competitiveness Report 2004-2005 |
| Correlations: |
| |
| |
More correlations » |
More correlations » |
Feeds |
Contact